8alpha-hydroxy-11beta, 13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening or / and resisting aging in saussurea involucrata and application of 8alpha-hydroxy-11beta, 13-dihydrodehydrocostus lactone sesquiterpene lactone

The 8α-hydroxy-11β,13-dihydrodehydrogenated leucorolide sesquiterpene lactone separated by extraction and silica gel column chromatography activated the Nrf2/Keap1 signaling pathway, solving the unclear efficacy of Tianshan Snow Lotus extract and The cumbersome problem of cell culture process has achieved effective application of Tianshan Snow Lotus in the fields of antioxidant and anti-aging.

CN118994073AActive Publication Date: 2024-11-22KUNMING INST OF BOTANY CHINESE ACAD OF SCI +1
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411079538.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-07
Publication Date
2024-11-22
Estimated Expiration
2044-08-07

AI Technical Summary

Technical Problem

The existing composition extraction method of Tianshan Snow Lotus extract is simple, the composition effect is unclear, and the cell culture process is cumbersome and not suitable for large-scale industrial production, which limits its in-depth research and application in the fields of whitening and anti-aging.

Method used

The obtained 8α-hydroxy-11β,13-dihydrodehydrogenated leucorolide sesquiterpene lactone was isolated by extraction and silica gel column chromatography, and extracted using a mixed solution of petroleum ether and ethyl acetate, and activated Nrf2/Keap1 The signaling pathway reduces the ROS level of HepG2 cells and enhances antioxidant enzyme activity, and is used to prepare antioxidant and anti-aging compositions.

Benefits of technology

The effective extraction and purification of 8α-hydroxy-11β,13-dihydrodehydrogenated leucorolide in Tianshan Snow Lotus has been achieved, which reduces the oxidative stress of HepG2 cells, has anti-aging and whitening effects, and is suitable for antioxidant drugs and Cosmetics development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118994073A_ABST
    Figure CN118994073A_ABST
Patent Text Reader

Abstract

The invention discloses 8alpha-hydroxy-11beta, 13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening or / and resisting aging in saussurea involucrata and application, the structural formula of the 8alpha-hydroxy-11beta, 13-dihydrodehydrocostus lactone sesquiterpene lactone is as follows: # imgabs0. The compound can reduce the level of ROS in HepG2 cells, improve the activity of antioxidant enzymes CAT, SOD and GSH, reduce the content of MDA and improve oxidative stress of the HepG2 cells. The compound can be used for preparing an anti-oxidation and anti-aging composition, and the substance can be used for preparing an anti-oxidation and anti-aging composition for improving oxidative stress of HepG2 cells.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of Saussurea involucrata, and in particular to an 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone in Saussurea involucrata for whitening and / or anti-aging, and its application. Background Art

[0002] Saussurea involucrata is the dried aerial part of the Asteraceae plant. Saussurea involucrata is warm in nature and slightly bitter in taste. It has the effects of warming the kidney and promoting yang, promoting menstruation and activating blood circulation. Modern research shows that it has anti-inflammatory and analgesic effects, blood lipid regulation, anti-obesity, anti-oxidation and anti-tumor effects.

[0003] Tianshan Saussurea has multiple effects on the skin, such as the Tianshan Saussurea extract and the skin care composition containing the same disclosed in CN202311765420.4. The snow lotus extract improves the extraction rate through the composite bio-enzyme-ultrasonic extraction technology to ensure the activity of the effective ingredients. The skin care composition containing the above-mentioned Tianshan Saussurea extract maintains the microecological balance of the skin by compounding lactobacillus, so as to more effectively resist the invasion of free radicals, reduce the speed of skin aging, and maintain the youthful state of the skin. At the same time, it also has the effects of strengthening the skin barrier, renewing skin cells, inhibiting melanin deposition, smoothing acne pits, reducing acne marks, improving skin texture and inhibiting acne regeneration, making the skin smooth as before.

[0004] However, the extraction method of the above composition is simple, and the effective components of the composition are unclear, which cannot be used for further in-depth research on the efficacy of snow lotus extract on the skin.

[0005] For example, CN202111406538.9 discloses a composition containing Tianshan Saussurea cell culture, its preparation method and application, the raw materials of the composition include: Tianshan Saussurea cell culture and Schisandra chinensis, with a mass ratio of 1:3 to 4:1; the preparation method of the composition includes: S1, mixing Tianshan Saussurea cell culture, Schisandra chinensis and 1,3-butanediol, and hot reflux extraction; S2, fine filtration and compounding resveratrol to obtain the composition; the above composition has application in the preparation of anti-inflammatory and / or whitening products. The process of obtaining Tianshan Saussurea cell culture is cumbersome, the production process is complicated, and the production requirements are high, which is not suitable for large-scale industrial production.

[0006] The information disclosed in the background technology section is only intended to enhance the understanding of the overall background of the invention and should not be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art. Summary of the invention

[0007] In view of the above technical problems, the present application provides a kind of 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone from Saussurea involucrata for whitening and / or anti-aging, and its application. The substance is safe and non-toxic, can effectively improve the oxidative stress of HepG2 cells and exert antioxidant effect.

[0008] The present application provides an 8-hydroxy-11-hydroxy-11-hydroxy-2-nitropropene from Tianshan Saussurea involucrata for whitening and / or anti-aging.

[0009] ,13-Dihydrodehydrocostus lactone sesquiterpene lactone, the structural formula is as follows:

[0010]

[0011] Preferably, the preparation method comprises the following steps: extracting and separating the raw materials by silica gel column chromatography;

[0012] The raw material is Tianshan Snow Lotus or Centaurea canariensis of the Asteraceae family.

[0013] Preferably, when using Saussurea involucrata as raw material, the Saussurea involucrata is subjected to alcohol extraction before extraction, and the alcohol extract is suspended in water; the extractant is a mixed solution of petroleum ether and ethyl acetate;

[0014] Preferably, when the Asteraceae plant Centaurea canariensis is used as the raw material, the extraction solvent is diethyl ether and petroleum ether in a volume ratio of 1:2.

[0015] The natural compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone can be obtained by extraction and separation from the plant Saussurea tianshanica by various existing methods. For example, Saussurea tianshanica is used as a raw material and extracted by hot reflux with 95% ethanol, the ethanol extract is suspended in water, and extracted by petroleum ether and ethyl acetate respectively, and the ethyl acetate segment is separated by silica gel column chromatography to obtain the compound.

[0016] In addition, the compound can also be extracted and separated from Centaurea canariensis, a plant of the Asteraceae family distributed in high altitude areas of Chile. The main steps are extraction with a mixed solvent of ether and petroleum ether (volume ratio 1:2), and repeated silica gel column chromatography and preparative thin layer method. The substance belongs to the sesquiterpene lactone compound.

[0017] This compound reduces the ROS level of HepG2 cells by activating the Nrf2 / Keap1 signaling pathway, enhances the activity of antioxidant enzymes CAT, SOD and GSH, reduces the MDA content, and improves oxidative stress. It can be used as an antioxidant drug or cosmetic.

[0018] Preferably, 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone has no cytotoxicity to HepG2 cells when the concentration is less than or equal to 50 μM.

[0019] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than or equal to 12.5 μM, the ROS content in the cell after H2O2 stimulation can be reduced. More preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5 to 50 μM, the ROS content in the cell after H2O2 stimulation can be reduced. Also included: when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 25 μM.

[0020] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than or equal to 12.5 μM, the ROS content in HepG2 cells induced by H2O2 is reduced;

[0021] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5-50 μM, the ROS content in HepG2 cells induced by H2O2 is reduced.

[0022] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than 6.25 μM, it can reverse the down-regulation of CAT and GSH in HepG2 cells induced by H2O2; more preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 6.25-25 μM, it can reverse the down-regulation of CAT and GSH in HepG2 cells induced by H2O2;

[0023] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than 12.5 μM, it can reverse the down-regulation of SOD in HepG2 cells induced by H2O2;

[0024] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5 to 25 μM, it can reverse the down-regulation of SOD in HepG2 cells induced by H2O2;

[0025] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than 6.25 μM, it can reverse the upregulation of MDA in HepG2 cells induced by H2O2;

[0026] Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 6.25-25 μM, it can reverse the up-regulation of MDA in HepG2 cells induced by H2O2.

[0027] Preferably, 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone can reverse the downregulation of Nrf2 and Keap1 mRNA and improve cellular oxidative damage;

[0028] Preferably, 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone can activate the Nrf2 / Keap1 signaling pathway for antioxidant effect.

[0029] Another aspect of the present application provides an anti-aging composition, comprising at least: the above-mentioned 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone.

[0030] Preferably, the composition comprises: cosmetic excipients or pharmaceutical excipients.

[0031] The added auxiliary materials can be selected from the common auxiliary materials in the field according to the use of the composition to be prepared. For example, the composition can be prepared into a skin care cream, essence, isolation cream, isolation milk, BB cream, foundation or toner; when preparing corresponding types of cosmetics, corresponding auxiliary materials can be selected.

[0032] The added excipients can be selected from the common excipients in the art according to the pharmaceutical preparation to be prepared, for example, they can be combined to form tablets, granules, pills, capsules or injections.

[0033] Another aspect of the present application also provides an antioxidant composition, comprising at least: the above-mentioned 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone.

[0034] Preferably, the composition comprises: cosmetic excipients or pharmaceutical excipients.

[0035] The added auxiliary materials can be selected from the common auxiliary materials in the field according to the use of the composition to be prepared. For example, the composition can be prepared into a skin care cream, essence, isolation cream, isolation milk, BB cream, foundation or toner; when preparing corresponding types of cosmetics, corresponding auxiliary materials can be selected.

[0036] For example, the combination can be made into tablets, granules, pills, capsules or injections.

[0037] The beneficial effects of this application include:

[0038] 1) 8-Hydroxy-11-nitropropene from the Saussurea involucrata provided in the present application for whitening and / or anti-aging

[0039] ,13-Dihydrodehydrocostus lactone sesquiterpene lactone, application, separation and purification of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone in Tianshan Snow Lotus and study of its pharmacological effects are of great significance for the development and utilization of Tianshan Snow Lotus resources in the field of anti-aging and whitening cosmetics or antioxidant drugs.

[0040] 2) 8-Hydroxy-11-nitropropene from the Saussurea involucrata provided in the present application for whitening and / or anti-aging

[0041] ,13-Dihydrodehydrocostus lactone sesquiterpene lactone, application, the compound can reduce the level of ROS in HepG2 cells, increase the activity of antioxidant enzymes CAT, SOD and GSH, reduce the content of MDA, and improve the oxidative stress of HepG2 cells. The compound can be used to prepare antioxidant and anti-aging compositions, and the substance can be used to prepare and improve the oxidative stress of HepG2 cells. The substance has the function of anti-aging of the skin, and can effectively inhibit the deposition of spots, thereby achieving the effects of whitening and anti-oxidation. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] Figure 1 This is a graph showing the results of the CCK-8 method in the present application example in detecting the toxic effects of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 10, 20, 30, 40, and 50 μM on HepG2 cells;

[0043] Figure 2 This is a result diagram obtained by flow cytometry detection of the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 12.5, 25, and 50 μM on the ROS content of oxidatively damaged HepG2 cells in the embodiment of the present application; Figure 2 (A), the horizontal axis represents the fluorescence intensity, and the vertical axis represents the number of collected cells. Figure 2 A shows the results of the blank group, the hydrogen peroxide-induced model group (H2O2), the positive control group (Vc), and the treatment groups with 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 50, 25, and 12.5 μM. Figure 2 (B) Yes Figure 2 (A) Quantification results. Compared with the blank control group, P ### <0.001; compared with the model, P***<0.001, P**<0.01.

[0044] Figure 3 This is a graph showing the results of the antioxidant enzyme activity test in the present application example, wherein Figure 3 (A) is the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on CAT activity; Figure 3 (B) is the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on SOD activity; Figure 3 (C) is the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the activity of GSH; Figure 3(D) is the effect of the compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on MDA activity; the blank group is the normal culture group of HepG2 cells, H2O2 is the model group induced by hydrogen peroxide, and the horizontal axes 50, 25, and 12.5 represent the treatment groups with different concentrations of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone; Figure 3 The "-" in the horizontal axis means that the corresponding substance at the end is not added, and the "+" represents the substance at the end. C584 is 8α-hydroxy-11β,13-dihydrodehydrocostus lactone. The data are expressed as average values.

[0045] ±SD, compared with blank, P ### <0.001; compared with the model, P***<0.001, P**<0.01.

[0046] Figure 4 This is a graph showing the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the mRNA expression of Nrf2 and Keap1 at the transcription level using the PCR method in the present application example, wherein Figure 4 (A) Effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the mRNA expression of Nrf2; Figure 4 (B) is the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the mRNA expression of Keap1; the groups and references corresponding to the horizontal axis are as follows: Figure 3 ; Data are expressed as mean ± SD, compared with blank, P ### <0.001; compared with the model, P***<0.001, P**<0.01.

[0047] Figure 5 This is a graph showing the results of detecting the activation of the Nrf2 / Keap1 signaling pathway by the compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone to improve oxidative damage in HepG2 cells in the examples of this application by Western blotting. Figure 5 (A) Effects of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the expression of key proteins in the Nrf2 / Keap1 signaling pathway; Figure 5 (B) is the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on Nrf2 protein expression; Figure 5 (C) shows the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on Keap1 protein expression; grouping and reference are as follows Figure 3 ; Data are expressed as mean ± SD, compared with blank, P ### <0.001; compared with the model, P***<0.001, P**<0.01. DETAILED DESCRIPTION

[0048] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments, but the present invention is not limited in any way. Any changes or improvements made based on the teachings of the present invention fall within the protection scope of the present invention.

[0049] Example

[0050] Unless otherwise specified, the materials and instruments used in the following examples were obtained from commercial channels; the detection methods used were all existing methods unless otherwise specified.

[0051] Example 1 Preparation of sesquiterpene lactone compound (8α-hydroxy-11β,13-dihydrodehydrocostus lactone)

[0052] The substance is prepared by referring to the method disclosed in the existing literature (Sesquiterpene lactones from Saussureainvolucrata, Fitoterapia 82 (2011) 983-987), using Sausquiterpene tianshanensis as a raw material, crushing the Sausquiterpene tianshanensis, soaking it in 95% ethanol, extracting it three times by hot reflux of 95% ethanol, combining the extracts and concentrating them, suspending the extracts in water, extracting them with petroleum ether and ethyl acetate respectively, subjecting the ethyl acetate segment solution obtained by the extraction to silica gel column chromatography, eluting it with dichloromethane:methanol (50:1) to obtain 8α-hydroxy-11β,13-dihydrodehydrocostus lactone, and the yield of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone is 0.0016%.

[0053] Example 2 Sesquiterpene lactone compound (8α-hydroxy-11β,13-dihydrodehydrocostus lactone) prevents oxidative stress in HepG2 cells

[0054] (1) Experimental cells

[0055] HepG2 cells were purchased from Procell Life Science & Technology Co., Ltd (Wuhan, China).

[0056] (2) Instruments and reagents

[0057] Full wavelength microplate reader (Thermo Fisher);

[0058] CO2 incubator (Thermo Fisher);

[0059] Centrifugal sedimentation device (Shanghai Surgical Instrument Factory);

[0060] Micro desktop refrigerated centrifuge (D-37520TherMo);

[0061] Flow cytometer (Becton Dickinson and Company);

[0062] Nanodrop 20000 ultra-micro-volume spectrophotometer (Thermo Fisher);

[0063] QuantStudio 3and 5Real Time PCR (Thermo Fisher);

[0064] Electrophoresis apparatus (EPS600 Tanon);

[0065] Transfer tank (Mini-PROTEAN Tetra SysteM, BIO-RAD);

[0066] Multicolor fluorescence, chemiluminescence and visible light imager (ProteinsiMple FluorcheM Q);

[0067] Fetal bovine serum (Pnosel);

[0068] DMEM medium (Pnosai);

[0069] Penicillin-streptomycin mixture (Beijing Solebow Technology Co., Ltd.);

[0070] Trypsin digestion solution (Shanghai Bio-Tech Co., Ltd.);

[0071] CAT Hydrogen Peroxide Test Kit (Nanjing Jiancheng Biotechnology Co., Ltd.)

[0072] SOD superoxide dismutase test kit (Nanjing Jiancheng Biotechnology Co., Ltd.)

[0073] GSH reduced glutathione test kit (Nanjing Jiancheng Biotechnology Co., Ltd.)

[0074] MDA Malondialdehyde Test Kit (Nanjing Jiancheng Biotechnology Co., Ltd.)

[0075] DCFH-DA (Shanghai Bio-Tech Biotechnology Co., Ltd.)

[0076] Ascorbic acid (Aladdin)

[0077] Cell lysis buffer RIPA (strong) (Shanghai Bio-Tech Biotechnology Co., Ltd.);

[0078] Trizol reagent (Thermo Fisher);

[0079] PMSF (protease inhibitor, Beijing Solebow Technology Co., Ltd.);

[0080] protein phosphatase inhibitors (Beijing Solebow Technology Co., Ltd.);

[0081] BCA protein concentration determination kit (Beijing Solebow Technology Co., Ltd.);

[0082] 5× protein loading buffer (Beijing Solebow Technology Co., Ltd.);

[0083] Rainbow 180 spectral protein marker (Beijing Solebow Technology Co., Ltd.);

[0084] PVDF membrane (Immobilon-P SQ Transfer Membrane.Merck Millpore Ltd.,pore size:0.2μM);

[0085] ECL Plus ultra-sensitive luminescent liquid (Beijing Solebow Technology Co., Ltd.);

[0086] Tris-base, tris(hydroxymethyl)aminomethane, sodium dodecyl sulfate (SDS), glycine (Beijing Solebao Technology Co., Ltd.)

[0087] TBST (Wuhan Saiweier Biotechnology Co., Ltd.);

[0088] 8α-Hydroxy-11β,13-dihydrodehydrocostus lactone: prepared from Saussurea involucrata. For the specific preparation method, see Example 1.

[0089] The primers used are as follows:

[0090] Table 1 Primer sequences

[0091]

[0092] The sources of antibodies used in Table 1 are as follows:

[0093] Primary Antibody

[0094] β-Actin Mouse MAb Antibody (Proteintech, 66009);

[0095] NRF2,NFE2L2 Polyclonal antibody(Proteintech, 16396-1-AP)

[0096] KEAP1 Polyclonal antibody (Proteintech, 10503-2-AP);

[0097] Secondary Antibodies

[0098] HRP (horseradish peroxidase)-labeled rabbit anti-goat IgG (Wuhan Saiweier Biotechnology Co., Ltd.);

[0099] HRP-labeled goat anti-mouse IgG (Wuhan Saiweier Biotechnology Co., Ltd.).

[0100] (3) Experimental methods

[0101] 1) CCK-8 assay to determine cell viability

[0102] HepG2 cells were cultured in DMEM complete medium containing 10% fetal bovine serum and 1% penicillin-streptomycin mixture in a 37°C, 5% CO2 incubator. When the cell confluence reaches 79-83%, they can be passaged. Carefully discard the cell supernatant and wash 2-3 times with 2 mL PBS buffer.

[0103] Subsequently, 1 mL of trypsin digestion solution was added for 2 minutes, and then 2 mL of DMEM complete medium was added in time to stop digestion. The cells were completely blown down, collected into a centrifuge tube, and placed in a centrifuge for 5 minutes at 1050 rpm.

[0104] The supernatant was discarded, 1 mL of DMEM complete medium was added, and the cell suspension was formed by gently pipetting.

[0105] Finally, 300 μL of the cell suspension was pipetted and added into sterilized clean culture flasks, and 3 mL of DMEM complete medium was added to each culture flask.

[0106] HepG2 cells in logarithmic growth phase were cultured at a density of 2×10 5 10 μmol / mL were inoculated in a 96-well plate and incubated in a constant temperature incubator for 24 hours. After incubation for 24 hours, the blank group was replaced with a new DMEM medium after filtering out the original culture medium, and the drug-treated group was replaced with: DMEM medium containing 8α-hydroxy-11β,13-dihydrodehydrocostus lactone prepared in advance and at a concentration of 10, 20, 30, 40, and 50 μmol / L. After incubation in the incubator for 24 hours, 10 μL of CCK-8 solution (protected from light) was added to each well. Incubate in a 37°C oven for 40 minutes, shake and mix with an enzyme reader, and measure the OD value of the solution obtained in the blank group and the drug-treated group at a wavelength of 450 nm. The blank group and drug-treated group experiments were repeated 3 times and the results were analyzed.

[0107] 2) Detection of ROS content in oxidative stress HepG2 cells by flow cytometry

[0108] HepG2 cells were cultured in DMEM complete medium containing 10% fetal bovine serum and 1% penicillin-streptomycin mixture. When the cell confluence reached 79-83%, 2.5×10 5The cells were carefully and evenly inoculated in a 6-well plate at a density of 100 / mL and placed in a 37°C, 5% CO2 incubator for culture. After about 24 hours, the cells adhered to the wall, and the blank control group ( Figure 2 B is control), model group ( Figure 2 The horizontal axis in B is H2O2), the old culture medium was discarded and new DMEM complete culture medium was added to the positive drug-treated group; the DMEM complete culture medium containing 50 μM ascorbic acid (Vc) was replaced in the positive drug-treated group; the old culture medium was discarded in the compound-treated group, and DMEM complete culture medium with 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 12.5, 25, and 50 μM was added and incubated for 24 hours.

[0109] After 24 h, the blank control group discarded the original culture medium and added new DMEM culture medium, while the model group, positive drug administration group and compound treatment group were replaced with DMEM culture medium containing 500 μM H2O2 (protected from light).

[0110] After 4 hours of modeling induced by the above method, the supernatant was discarded, and 2 mL of cell culture medium containing DCFH-DA probe (final concentration of 10 μM) was added and incubated in the dark for 20 to 30 minutes. After the incubation, the supernatant was discarded, and the cells were rinsed twice with PBS buffer, and 0.5 mL of trypsin was added to each well for digestion for 2 minutes, and the cells were collected by blowing PBS.

[0111] The cell suspension was collected into a 1.5 mL centrifuge tube and centrifuged at 1000 rpm for 5 min. After obtaining the precipitate, 0.5 mL of PBS buffer was added to resuspend the cells. After passing through a 300-mesh nylon sieve, the ROS (reactive oxygen) content in the cells was detected by flow cytometry.

[0112] 3) The effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the antioxidant capacity of HepG2 cells induced by H2O2 was detected by CAT, SOD, GSH and MAD kits

[0113] Cell culture, group setting and treatment methods were the same as those in Experiment 2). Cells were collected 4 hours after modeling and centrifuged to obtain cell pellets. 200 μL of cell lysis buffer (prepared and mixed at a volume ratio of RIPA strong lysis buffer: phosphatase inhibitor: PMSF of 100:1:1, prepared before use) was added to the cell pellet and lysed on ice for 30 min. The broken cell samples were obtained and used to determine protein concentration and enzyme activity. For specific determination steps, see the instructions for use of CAT, SOD, GSH and MAD kits.

[0114] 4) PCR detection of the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on mRNA expression of oxidative factors

[0115] 4.1 RNA extraction

[0116] Cell culture, group setting and treatment methods were the same as above. Cells were collected 4 h after modeling. The cell culture medium was discarded, and the cells were rinsed twice with PBS buffer and the waste liquid was discarded. 1 mL of Trizol reagent was added to fully cover the cell surface, and then the cells were repeatedly blown with a pipette to make them fall off. The lysate was transferred to a 1.5 mL enzyme-free centrifuge tube and repeatedly blown with a pipette until it was fully lysed, and then stood at room temperature for 5 min. After adding 0.2 mL of chloroform, the tube was tightly capped and shaken vigorously for 15 s, and incubated at room temperature for 2-3 min. Centrifuged at 4°C and 12000r for 15 min, the mixture was separated into three phases, and 0.5 mL of the upper aqueous phase was carefully transferred to a new 1.5 mL enzyme-free centrifuge tube, 0.5 mL of isopropanol was added to precipitate RNA, inverted and mixed, and incubated on ice for 10 min; centrifuged at 12000r for 10 min, and the RNA precipitate was collected. The supernatant was discarded and the residual liquid was completely removed with a pipette. Wash the RNA precipitate once with 75% ethanol, add 1 mL of 75% ethanol, vortex to mix the sample solution, and then centrifuge at 7500r for 5 min at 4°C; repeat the wash once. Completely remove the ethanol and air-dry the RNA precipitate for 10 min.

[0117] 4.2 Reverse transcription reaction

[0118] ① RNA volume: The required RNA mass is 1000 ng, X (RNA volume) = 1000 ng / RNA concentration (ng / μL), calculate the RNA volume.

[0119] ② Synthesize cDNA: Use RNA with gDNA removed as template to prepare cDNA. The reaction system for removing gDNA is shown in Table 2. After sufficient mixing, reverse transcription is performed according to the reaction conditions. The reverse transcription conditions are shown in Table 3. Note: X (RNA volume) = 1000 ng / RNA concentration (ng / μL).

[0120] Table 2 Reaction for removing gDNA

[0121]

[0122]

[0123] Table 3 Reverse transcription reaction system

[0124]

[0125] 4.3 Polymerase chain reaction

[0126] Table 4 PCR amplification system

[0127]

[0128] ③Except for the cDNA solution, the other reagents were prepared in advance, mixed and transferred to the 8-tube strip, and the cDNA solution was added last. Amplification was performed using the QuantStudio 3 Real Time PCR System instrument. -△△Ct The relative expression was calculated by the β-actin method, with β-actin as the internal reference.

[0129] 5) Western blot was used to detect the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the expression level of related proteins in cells

[0130] 5.1 Extraction of total protein from cells

[0131] In accordance with the method in "1) CCK-8 method to determine cell viability", cells were inoculated into 6-well plates, and blank control group, model group and compound treatment group were set up, and incubation was continued for 48 hours. The supernatant was discarded, and the cells were gently washed twice with PBS solution. 1 mL PBS was added to each well, and the cells were completely blown down with a pipette, transferred to a 1.5 mL ep tube, and the cells were collected by centrifugation to obtain a cell pellet. Cell lysis mixture was added to the cell pellet (prepared and mixed at a volume ratio of RIPA strong lysis solution: phosphatase inhibitor: PMSF of 100:1:1, and prepared before use), and lysed on ice for 30 minutes.

[0132] The lysate was centrifuged at 4℃ and 3500r / min for 10min, the supernatant was aspirated and the volume was recorded. The protein loading buffer was added to the supernatant at a volume ratio of 1:4, and the protein was denatured by heating in a metal bath at 100℃ for 10min, and then cooled to room temperature and stored in a -20℃ refrigerator.

[0133] 5.2 Determination of protein concentration

[0134] The protein concentration in the obtained sample solution was detected according to the instructions of the BCA protein concentration determination kit, and the absorbance value of the sample solution at a wavelength of 562nm was detected using an enzyme marker. The protein concentration in the sample was calculated based on the obtained curve after the standard curve was drawn according to the instructions.

[0135] 5.3 Glue making

[0136] Prepare 10% separation gel and 5% stacking gel according to Table 1

[0137] Table 1 Separation gel and concentration gel ratio system

[0138]

[0139] 5.4 Electrophoresis

[0140] Add marker and protein sample, transfer the gel to the electrophoresis tank after loading, adjust the voltage to 80V, run for 30 minutes, then adjust the voltage to 120V, continue running until the gap between the marker bands near the target protein is separated, then stop the electrophoresis.

[0141] 5.5 Transfer

[0142] Cut off the gel containing the target protein, compare the size of the gel, cut off the PVDF membrane and place it in methanol for activation for 2 to 3 minutes. Transfer the gel to the PVDF membrane and put it into the transfer tank for transfer. Set the voltage to 72V for 60 minutes. During the operation, use 1× transfer buffer (first prepare 10× transfer buffer: weigh 30.3g Tris-base, 142.6g glycine, dissolve it in ultrapure water and dilute to 1L. 1× transfer buffer preparation: add 350mL ultrapure water and 100mL methanol to 50mL 10× transfer buffer in turn, mix well) to keep it moist, avoid dehydration of the gel, and avoid the formation of bubbles.

[0143] 5.6 Closure

[0144] After the transfer, the PVDF membrane was taken out, marked, placed in 5% skimmed milk powder, and placed on a shaker at room temperature to block for 2 hours.

[0145] 5.7 Primary Antibody Incubation

[0146] After blocking, rinse the PVDF membrane with skim milk powder in TBST, cut the target band according to the molecular weight indicated by Maker and mark it. Incubate the band in the corresponding primary antibody on a shaker at 4°C overnight. After incubation, wash the membrane 5 times with TBST, 5 minutes each time.

[0147] 5.8 Secondary Antibody Incubation

[0148] Take out the washed bands, put them into the corresponding secondary antibody, and incubate them at room temperature for 2 hours. Wash the membrane 5 times, 5 minutes each time.

[0149] 5.9 Development

[0150] ECL Plus ultra-sensitive luminescent liquid was evenly coated on the strips, and the strips were exposed and developed using a developer. β-actin was used as an internal reference, and the grayscale value of the strips was quantitatively analyzed using Image J software.

[0151] 5.10 Data Analysis

[0152] SPSS19.0 software was used for one-way ANOVA, and the experimental results were expressed as mean standard deviation. GraphPad Prism 7.0 software was used to analyze all columnar images, and P < 0.05 was considered statistically significant.

[0153] (6) Analysis and discussion of experimental results

[0154] 6.1 The CCK-8 method was used to detect the toxic effects of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 10, 20, 30, 40, and 50 μmol / L on HepG2 cells (see "1) CCK-8 method for cell viability determination" for the experimental process). The results are as follows Figure 1 As shown in the figure, compared with the blank group, 8 α 8α-hydroxy-11β,13-dihydrodehydrocostus lactone had no cytotoxicity to HepG2 cells in the concentration range of 10 to 50 μM, so a concentration less than 50 μM was selected for activity screening of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone.

[0155] 6.2 Experiment "2) Detection of ROS content in HepG2 cells under oxidative stress by flow cytometry" The cell oxidative stress model was established by H2O2, and the ROS content in HepG2 cells was detected by flow cytometry. The results are as follows Figure 2 As shown in the results of each treatment group in (A), it can be seen that: compared with the blank group, after H2O2 stimulation, flow cytometry detection found that the peak of the model group after H2O2 stimulation was significantly shifted to the right, and the intracellular fluorescence intensity was enhanced, indicating that the intracellular ROS content increased at this time. After the administration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 12.5, 25, and 50 μM, the peak shape was significantly shifted to the left, indicating that the fluorescence intensity became weaker, indicating that the intracellular ROS content decreased at this time.

[0156] Figure 2 As shown in (B), the blank control group did not add H2O2, so the ROS content was low. 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at 50, 25 and 12.5μM can reduce the ROS content of HepG2 cells to varying degrees, and at 25 and 12.5μM, it significantly improved the oxidative stress of HepG2 cells (P<0.001). At concentrations of 25 and 12.5μM, the inhibitory effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the production of ROS in HepG2 cells induced by H2O2 was lower than that of VC, indicating that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone can inhibit the production of ROS in HepG2 cells induced by H2O2, reduce intracellular oxidative stress, and avoid cell damage.

[0157] 6.3 Figure 3 The results of experiment "3) Detecting the effect of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the antioxidant capacity of HepG2 cells induced by H2O2 using CAT, SOD, GSH and MAD kits" are as follows: Figure 3 As shown in A to D, compared with the blank control group (yellow column, i.e., neither H2O2 nor C584 was added), the test results of CAT, SOD and GSH in the model group (blue data column, i.e., the treatment group with only H2O2 added) showed that the antioxidant activity was significantly downregulated (P<0.001), and the MDA activity was significantly upregulated (P<0.001); 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone concentrations of 25, 12.5 and 6.25 μM could significantly reverse the downregulation of CAT and GSH caused by H2O2 (P<0.001);

[0158] At 25 and 12.5 μM, it was able to significantly reverse the downregulation of SOD caused by H2O2 (P<0.001);

[0159] At 25, 12.5 and 6.25 μM, it was able to significantly reverse the upregulation of MDA caused by H2O2 (P<0.001).

[0160] It shows that the addition of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone can enhance the activity of antioxidant enzymes CAT, SOD and GSH, reduce MDA activity, reduce intracellular oxidative stress response and avoid cell damage.

[0161] The antioxidant mechanism of this compound is expected to be further explored.

[0162] The above studies have proved that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone has a good effect in reducing the ROS content of oxidatively damaged HepG2, increasing the activities of CAT, SOD and GSH, and reducing the activity of MDA. Therefore, in order to further clarify the mechanism of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone in improving oxidative damage, PCR and Western blot methods were used to detect its effect on the signaling pathway in HepG2 cells.

[0163] The results of experiment 6.4 “PCR detection of the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the mRNA expression of oxidative factors” can be found in Figure 4 , Figure 4 The PCR experiment was used to detect the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the mRNA expression of Nrf2 and Keap1 at the transcriptional level. The results are shown in Figure 4As shown in A and B, compared with the blank control group (yellow column, i.e., neither H2O2 nor C584 was added), the model group (blue data column, i.e., the treatment group with only H2O2 added) showed a significant downregulation of Nrf2 and Keap1 mRNA expression (P<0.001), while the 8α-hydroxy-11β,13-dihydrodehydrocostus lactone treatment group was able to significantly reverse the downregulation of Nrf2 and Keap1 mRNA caused by H2O2 (P<0.001). This suggests that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone may improve oxidative damage in HepG2 cells through the Nrf2 / Keap1 signaling pathway.

[0164] The results of experiment 6.5 "Western blot analysis of the effect of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the expression level of related proteins in cells" are as follows Figure 5 As shown in A to C, in this experiment, H2O2 was used to treat cells, causing oxidative stress to the cells, blocking the Nrf2 / Keap1 signaling pathway, and the protein levels of the related signaling pathways were as follows: Figure 5 See Figure 5 A shows that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone has no effect on the expression of β-actin, but has an effect on the expression of Keap1 and a significant effect on the expression of Nrf2; Figure 5 (B) and 5 (C) respectively show the effects of compound 8α-hydroxy-11β,13-dihydrodehydrocostus lactone on the expression of Nrf2 and Keap1 proteins. Figure 5 (B) Indicates that the expression level of Keap1 protein in HepG2 cells was increased after treatment with 8α-hydroxy-11β,13-dihydrodehydrocostus lactone at concentrations of 25 and 12.5 μM.

[0165] The results of this study showed that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone may exert antioxidant effects by activating the Nrf2 / Keap1 signaling pathway, indicating that 8α-hydroxy-11β,13-dihydrodehydrocostus lactone can be used in the research of antioxidant cosmetics or drugs.

[0166] Example 2 Toner containing 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone

[0167] 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone was added to sterile water to a concentration of 6.25 μM and mixed to obtain toner. The solubility of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone in water is 1 mg dissolved in 200 μL of water, and the toner was prepared according to this ratio.

[0168] Example 3 Injection containing 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone

[0169] 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone was added to sterile water to a concentration of 6.25 μM and mixed to obtain an injection. The solubility of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone in water is 1 mg can be dissolved in 200 μL of water, and the injection is prepared according to this ratio.

[0170] Although the present invention has been described in detail with reference to the aforementioned embodiments, it is still possible for those skilled in the art to modify the technical solutions described in the aforementioned embodiments, or to make equivalent substitutions for some of the technical features therein. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. An 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone from Saussurea involucrata for whitening and / or anti-aging, characterized in that: The structural formula is as follows:

2. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: 8α-Hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone had no cytotoxicity to HepG2 cells when the concentration was less than or equal to 50 μM; Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is greater than or equal to 12.5 μM, the ROS content in cells after H2O2 stimulation can be reduced; More preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5-50 μmol / L, the ROS content in cells after H2O2 stimulation can be reduced.

3. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: When the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone was greater than or equal to 12.5 μM, it reduced the ROS content in HepG2 cells induced by H2O2; Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5-50 μM, the ROS content in HepG2 cells induced by H2O2 is reduced.

4. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: When the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone was greater than 6.25 μM, it could reverse the down-regulation of CAT and GSH in HepG2 cells induced by H2O2; More preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 6.25-25 μM, it can reverse the down-regulation of CAT and GSH in HepG2 cells induced by H2O2.

5. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: When the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone was greater than 12.5 μM, it could reverse the down-regulation of SOD in HepG2 cells induced by H2O2; Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 12.5-25 μM, it can reverse the down-regulation of SOD in HepG2 cells induced by H2O2.

6. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: 8α-Hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone concentration greater than 6.25 μM can reverse the upregulation of MDA in HepG2 cells induced by H2O2; Preferably, when the concentration of 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone is 6.25-25 μM, it can reverse the up-regulation of MDA in HepG2 cells induced by H2O2.

7. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: 8α-Hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone can reverse the downregulation of Nrf2 and Keap1 mRNA and improve cell oxidative damage; Preferably, 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone can activate the Nrf2 / Keap1 signaling pathway for antioxidant effect.

8. The 8-hydroxy-11,13-dihydrodehydrocostus lactone sesquiterpene lactone for whitening and / or anti-aging in Saussurea involucrata according to claim 1, characterized in that: The preparation method comprises the following steps: extracting and separating the raw materials by silica gel column chromatography; The raw material is Tianshan Snow Lotus or Centaurea canariensis of Asteraceae; Preferably, when using Saussurea involucrata as raw material, the Saussurea involucrata is subjected to alcohol extraction before extraction, and the alcohol extract is suspended in water; the extractant is a mixed solution of petroleum ether and ethyl acetate; Preferably, when the Asteraceae plant Centaurea canariensis is used as the raw material, the extraction solvent is diethyl ether and petroleum ether in a volume ratio of 1:

2.

9. An anti-aging composition, characterized in that: At least comprising: 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone according to any one of claims 1 to 8; Preferably, the composition comprises: cosmetic excipients or pharmaceutical excipients.

10. An antioxidant composition, characterized in that At least comprising: the above-mentioned 8α-hydroxy-11β,13-dihydrodehydrocostus lactone sesquiterpene lactone; Preferably, the composition comprises: cosmetic excipients or pharmaceutical excipients.

Citation Information

Patent Citations

  • Applications and preparation method of saussurea total sesquiterpene lactone

    CN102106890A

  • Method for building Sinkiang Saussurea involucrate HPLC fingerprint

    CN102565257A

  • Application of hydroxytyrosol glycoside in preparation of anti-aging preparation

    CN116570605A

  • Extraction method of saussurea involucrata purple callus vesicles and application of saussurea involucrata purple callus vesicles in preparation of antioxidant or skin whitening products

    CN117180164A